Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Structural Heart Market Set To Climb From $17.31 Billion In 2026 To $24.6 Billion By 2030#_x000D_
The structural heart market has observed significant expansion in recent years. It is projected to increase from $15.89 billion in 2025 to $17.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. This historical growth can be attributed to several factors including the rising prevalence of valvular heart diseases, a globally aging population, the expansion of catheterization laboratories, the increasing adoption of transcatheter heart technologies, and a heightened awareness of minimally invasive cardiac care._x000D_
_x000D_
The structural heart market is projected to experience robust expansion over the coming years. It is anticipated to reach $24.6 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the projection period can be ascribed to several factors, including the increasing demand for transcatheter therapies, greater investments in structural heart programs, the broadening of cardiac centers of excellence, innovations in device miniaturization, and a heightened emphasis on lowering open-heart surgery rates. Key trends for this forecast timeframe encompass a greater uptake of transcatheter valve procedures, an increase in minimally invasive structural heart interventions, the expanding incorporation of advanced cardiac imaging, the development of catheter-based repair technologies, and a stronger emphasis on individualized patient treatment planning._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Structural Heart Market Growth Factors: What’s Supporting Expansion?#_x000D_
The increasing occurrence of cardiovascular disorders is projected to boost the growth of the structural heart market. These disorders are conditions impacting the heart and blood vessels, encompassing issues like coronary artery disease, heart failure, and stroke. The growing prevalence of cardiovascular disorders is mainly fueled by an aging population, evolving lifestyles and diets, and rising rates of obesity and diabetes. Structural heart devices and services offer diagnosis and treatment for structural heart anomalies or conditions affecting the valves, chambers, and surrounding tissues, employing minimally invasive procedures rather than open-heart surgery to provide efficient care with fewer complications. For instance, in September 2025, the British Heart Foundation, a UK charity, reported that over 7.6 million people across the UK—more than 4 million men and over 3.6 million women—are living with cardiovascular disease. Projections further suggest that, driven by an aging population and improved survival rates, this number might climb by approximately 1 million by 2030 and around 2 million by 2040. Thus, the increasing prevalence of cardiovascular disorders is propelling the growth of the structural heart market._x000D_
_x000D_
#Structural Heart Market Segment Landscape And Growth Outlook#_x000D_
The structural heart market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products_x000D_
2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure_x000D_
3) By End Users: Hospitals, Cardiac Centers_x000D_
_x000D_
Subsegments:_x000D_
1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders _x000D_
2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings _x000D_
3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons _x000D_
4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures _x000D_
_x000D_
#Structural Heart Market Industry Trends: What’s Reshaping Demand?#_x000D_
Leading firms within the structural heart market are innovating sophisticated products, including transcatheter edge-to-edge repair (TEER) systems, with the goal of improving minimally invasive treatment approaches for heart valve conditions. These TEER systems are essentially minimally invasive medical instruments employed in managing heart valve disorders, especially mitral valve regurgitation. As an example, in April 2024, Abbott Laboratories, a US-based medical device company, obtained approval for TriClip from the Food and Drug Administration (FDA), a US-based federal agency responsible for safeguarding public health. TriClip stands as an innovative transcatheter edge-to-edge repair (TEER) system. This minimally invasive apparatus is introduced via a leg vein, allowing for valve repair without requiring open-heart surgery, thereby suiting patients at increased risk because of age or pre-existing health complications. Its operation involves utilizing clips to secure and draw together the leaflets of the tricuspid valve, which consequently diminishes regurgitation and boosts blood flow._x000D_
_x000D_
#Structural Heart Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG _x000D_
_x000D_
#View The Full Structural Heart Market Report:#_x000D_
_x000D_
#Structural Heart Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.